Tvardi Therapeutics Statistics
Total Valuation
TVRD has a market cap or net worth of $246.05 million. The enterprise value is $257.25 million.
Important Dates
The next estimated earnings date is Thursday, August 21, 2025, before market open.
Earnings Date | Aug 21, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TVRD has 9.36 million shares outstanding. The number of shares has increased by 0.43% in one year.
Current Share Class | 9.36M |
Shares Outstanding | 9.36M |
Shares Change (YoY) | +0.43% |
Shares Change (QoQ) | +0.03% |
Owned by Insiders (%) | 14.53% |
Owned by Institutions (%) | 21.85% |
Float | 7.93M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.35
Current Ratio | 3.35 |
Quick Ratio | 3.19 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | -134.61% |
Revenue Per Employee | n/a |
Profits Per Employee | -$2.90M |
Employee Count | 12 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +107.47% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +107.47% |
50-Day Moving Average | 26.15 |
200-Day Moving Average | 17.76 |
Relative Strength Index (RSI) | 51.55 |
Average Volume (20 Days) | 35,964 |
Short Selling Information
The latest short interest is 519,622, so 5.55% of the outstanding shares have been sold short.
Short Interest | 519,622 |
Short Previous Month | 514,107 |
Short % of Shares Out | 5.55% |
Short % of Float | 6.55% |
Short Ratio (days to cover) | 0.26 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -28.01M |
Pretax Income | n/a |
Net Income | -34.77M |
EBITDA | -27.92M |
EBIT | -28.01M |
Earnings Per Share (EPS) | -$5.43 |
Full Income Statement Balance Sheet
The company has $22.31 million in cash and $36.04 million in debt, giving a net cash position of -$13.73 million or -$1.47 per share.
Cash & Cash Equivalents | 22.31M |
Total Debt | 36.04M |
Net Cash | -13.73M |
Net Cash Per Share | -$1.47 |
Equity (Book Value) | -15.12M |
Book Value Per Share | -15.72 |
Working Capital | 16.46M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -21.86M |
Capital Expenditures | n/a |
Free Cash Flow | -21.86M |
FCF Per Share | -$2.34 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TVRD does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -0.43% |
Shareholder Yield | -0.43% |
Earnings Yield | -14.28% |
FCF Yield | -8.97% |
Analyst Forecast
The average price target for TVRD is $59.20, which is 125.10% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $59.20 |
Price Target Difference | 125.10% |
Analyst Consensus | Strong Buy |
Analyst Count | 5 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |